Similar articles

• Disclosing clinical trial results: publicity, significance and independence.

  Liao SM, Sheehan M, Clarke S. Liao SM, et al. Am J Bioeth. 2009 Aug;9(8):W3-5. doi: 10.1080/15265160903088151. Am J Bioeth. 2009. PMID: 19998144 No abstract available.
• Disclosure of adverse clinical trial results--should legal immunity be granted to drug companies?

  Vernillo A. Vernillo A. Am J Bioeth. 2009 Aug;9(8):45-7. doi: 10.1080/15265160902939933. Am J Bioeth. 2009. PMID: 19998162 No abstract available.
• Respecting participant autonomy and the disclosure of clinical trial results.

  Oakley J. Oakley J. Am J Bioeth. 2009 Aug;9(8):38. doi: 10.1080/15265160902979806. Am J Bioeth. 2009. PMID: 19998158 No abstract available.
• The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--chapter 7: Informed consent and xenotransplantation clinical trials.

  Vanderpool HY. Vanderpool HY. Xenotransplantation. 2009 Jul-Aug;16(4):255-62. doi: 10.1111/j.1399-3089.2009.00546.x. Xenotransplantation. 2009. PMID: 19799766
• Voluntary informed consent in research and clinical care: an update.

  Cahana A, Hurst SA. Cahana A, et al. Pain Pract. 2008 Nov-Dec;8(6):446-51. doi: 10.1111/j.1533-2500.2008.00241.x. Pain Pract. 2008. PMID: 19000172 Review.